by The U.S. in vitro diagnostics market size is poised to grow by USD 41.62 billion by 2033 from USD 37.17 billion in 2023, exhibiting a CAGR of 2% during the forecast period 2024 to 2033.
Key Takeaways
- By product, the reagents segment dominated the market with the largest share of 67% in 2023.
- By test location, the point-of-care segment dominated the market in 2023.
- By technology, the Immunoassay segment is expected to dominate the market during the forecast period.
- By application, the infectious diseases segment led the market with the largest share in 2023.
- By application, the oncology segment is expected witness the fastest rate of growth during the forecast period of 2024-2033.
- By end user, the hospital segment held the dominating share of the market in 2023.
The U.S. in vitro diagnostics market refers to the sector involving medical devices and reagents used for diagnostic testing outside of the body. It encompasses various technologies such as molecular diagnostics, immunoassays, clinical chemistry, and others. This market plays a crucial role in healthcare by aiding in disease detection, monitoring, and treatment decisions.
Get a Sample Report: https://www.precedenceresearch.com/sample/3712
Growth Factors
Factors contributing to the growth of the U.S. in vitro diagnostics market include advancements in technology, increasing prevalence of chronic and infectious diseases, growing demand for personalized medicine, expanding geriatric population, rising awareness about early disease diagnosis, and supportive government initiatives aimed at improving healthcare infrastructure and accessibility.
U.S. In Vitro Diagnostics Market Scope
| Report Coverage | Details |
| U.S. Market Size in 2023 | USD 37.17 Billion |
| U.S. Market Size by 2033 | USD 41.62 Billion |
| Growth Rate from 2024 to 2033 | CAGR of 2% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product, By Test Location, By Technology, By Application, and By End User |
Read More: Road Rollers Market Size to Worth USD 6.97 Billion By 2033
Opportunities
The U.S. in vitro diagnostics market presents several opportunities for growth and innovation. These include the development of novel diagnostic tests with higher accuracy and efficiency, expansion of point-of-care testing to enhance patient convenience and healthcare efficiency, leveraging artificial intelligence and machine learning for data analysis and interpretation, and tapping into the potential of digital health platforms for remote monitoring and management of chronic conditions.
Challenges
Despite its growth prospects, the U.S. in vitro diagnostics market faces certain challenges. These include stringent regulatory requirements for product approval, reimbursement issues affecting the adoption of new diagnostic technologies, high costs associated with R&D and commercialization, concerns regarding data privacy and security in digital health solutions, and the need for standardized protocols and quality control measures to ensure the reliability and reproducibility of diagnostic tests.
U.S. In Vitro Diagnostics Market Companies
- Alere, Inc.
- Beckman Coulter
- BD
- Bio-Rad laboratories
- Danaher
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- bioMérieux, Inc
- Quest Diagnostics
- Illumina, Inc.
Data Sources and Methodology
To gather comprehensive insights on the Global U.S. in vitro diagnostics Market, we relied on a range of data sources and followed a well-defined methodology. Our approach involved interactions with industry experts and key stakeholders across the market’s value chain, including management organizations, processing organizations, and analytics service providers.
We followed a rigorous data analysis process to ensure the quality and credibility of our research. The gathered information was carefully evaluated, and relevant quantitative data was subjected to statistical analysis. By employing robust analytical techniques, we were able to derive meaningful insights and present a comprehensive overview of the Global U.S. in vitro diagnostics Market.
The most resonating, simple, genuine, and important causes because of which you must decide to buy the U.S. in vitro diagnostics market report exclusively from precedence research
- The research report has been meticulously crafted to provide comprehensive knowledge on essential marketing strategies and a holistic understanding of crucial marketing plans spanning the forecasted period from 2023 to 2032.
Key Features of the Report:
- Comprehensive Coverage: The report extensively encompasses a detailed explanation of highly effective analytical marketing methods applicable to companies across all industry sectors.
- Decision-Making Enhancement: It outlines a concise overview of the decision-making process while highlighting key techniques to enhance it, ensuring favorable business outcomes in the future.
- Articulated R&D Approach: The report presents a well-defined approach to conducting research and development (R&D) activities, enabling accurate data acquisition on current and future marketing conditions.
Market Segmentation:
By Product
- Reagents
- Instruments
- Services
By Test Location
- Point of Care
- Home Care
- Others
By Technology
- Immunoassay
- Instruments
- Reagents
- Services
- Hematology
- Instruments
- Reagents
- Services
- Clinical Chemistry
- Instruments
- Reagents
- Services
- Molecular Diagnostics
- Instruments
- Reagents
- Services
- Coagulation
- Instruments
- Reagents
- Services
- Microbiology
- Instruments
- Reagents
- Services
- Others
- Instruments
- Reagents
- Services
By Application
- Diabetes
- Cardiology
- Nephrology
- Infectious Disease
- Oncology
- Drug Testing
- Autoimmune Diseases
- Others
By End User
- Standalone Laboratories
- Hospitals
- Academic & Medical Schools
- Point-of-Care
- Others
Reasons to Consider Purchasing the Report:
- Enhance your market research capabilities by accessing this comprehensive and precise report on the global U.S. in vitro diagnostics market.
- Gain a thorough understanding of the overall market landscape and be prepared to overcome challenges while ensuring robust growth.
- Benefit from in-depth research and analysis of the latest trends shaping the global U.S. in vitro diagnostics market.
- Obtain detailed insights into evolving market trends, current and future technologies, and strategic approaches employed by key players in the global U.S. in vitro diagnostics market.
- Receive valuable recommendations and guidance for both new entrants and established players seeking further market expansion.
- Discover not only the cutting-edge technological advancements in the global U.S. in vitro diagnostics market but also the strategic plans of industry leaders.
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. In Vitro Diagnostics Market
5.1. COVID-19 Landscape: U.S. In Vitro Diagnostics Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global U.S. In Vitro Diagnostics Market, By Product
8.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Product, 2023-2032
8.1.1. Reagents
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Instruments
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global U.S. In Vitro Diagnostics Market, By Test Location
9.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Test Location, 2023-2032
9.1.1. Point of Care
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Home Care
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global U.S. In Vitro Diagnostics Market, By Technology
10.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Technology, 2023-2032
10.1.1. Immunoassay
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Hematology
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Clinical Chemistry
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
10.1.4. Molecular Diagnostics
10.1.4.1. Market Revenue and Volume Forecast (2020-2032)
10.1.5. Coagulation
10.1.5.1. Market Revenue and Volume Forecast (2020-2032)
10.1.6. Microbiology
10.1.6.1. Market Revenue and Volume Forecast (2020-2032)
10.1.7. Others
10.1.7.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global U.S. In Vitro Diagnostics Market, By Application
11.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Application, 2023-2032
11.1.1. Diabetes
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Cardiology
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
11.1.3. Nephrology
11.1.3.1. Market Revenue and Volume Forecast (2020-2032)
11.1.4. Infectious Disease
11.1.4.1. Market Revenue and Volume Forecast (2020-2032)
11.1.5. Oncology
11.1.5.1. Market Revenue and Volume Forecast (2020-2032)
11.1.6. Drug Testing
11.1.6.1. Market Revenue and Volume Forecast (2020-2032)
11.1.7. Autoimmune Diseases
11.1.7.1. Market Revenue and Volume Forecast (2020-2032)
11.1.8. Others
11.1.8.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global U.S. In Vitro Diagnostics Market, By End User
12.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by End User, 2023-2032
12.1.1. Standalone Laboratories
12.1.1.1. Market Revenue and Volume Forecast (2020-2032)
12.1.2. Hospitals
12.1.2.1. Market Revenue and Volume Forecast (2020-2032)
12.1.3. Academic & Medical Schools
12.1.3.1. Market Revenue and Volume Forecast (2020-2032)
12.1.4. Point-of-Care
12.1.4.1. Market Revenue and Volume Forecast (2020-2032)
12.1.5. Others
12.1.5.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 13. Global U.S. In Vitro Diagnostics Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.1.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.1.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.1.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.6.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.1.6.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.1.6.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.1.6.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.7.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.1.7.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.1.7.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.1.7.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.2.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.2.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.2.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.6.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.2.6.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.2.7. Market Revenue and Volume Forecast, by Application (2020-2032)
13.2.8. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.9.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.2.9.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.2.10. Market Revenue and Volume Forecast, by Application (2020-2032)
13.2.11. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.12.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.2.12.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.2.12.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.2.13. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.14.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.2.14.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.2.14.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.2.15. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.3.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.3.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.3.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.6.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.3.6.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.3.6.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.3.7. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.8.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.3.8.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.3.8.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.3.9. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.10.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.3.10.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.3.10.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.3.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.11.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.3.11.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.3.11.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.3.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.4.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.4.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.4.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.6.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.4.6.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.4.6.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.4.7. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.8.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.4.8.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.4.8.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.4.9. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.10.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.4.10.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.4.10.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.4.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.11.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.4.11.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.4.11.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.4.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.5.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.5.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.5.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.6.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.5.6.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.5.6.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.5.7. Market Revenue and Volume Forecast, by End User (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.8.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)
13.5.8.3. Market Revenue and Volume Forecast, by Technology (2020-2032)
13.5.8.4. Market Revenue and Volume Forecast, by Application (2020-2032)
13.5.8.5. Market Revenue and Volume Forecast, by End User (2020-2032)
Chapter 14. Company Profiles
14.1. Alere, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Beckman Coulter
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. BD
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Bio-Rad laboratories
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Danaher
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Abbott Laboratories
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Thermo Fisher Scientific Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. bioMérieux, Inc
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Quest Diagnostics
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Illumina, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Unlocking Market Insights through Data Excellence
The “Precedence Statistics” flexible dashboard is a powerful tool that offers real-time news updates, economic and market forecasts, and customizable reports. It can be configured to support a wide range of analysis styles and strategic planning needs. This tool empowers users to stay informed and make data-driven decisions in various scenarios, making it a valuable asset for businesses and professionals looking to stay ahead in today’s dynamic and data-driven world.
Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com
Precedence Statistics – Empowering Your Data Insights
Contact Us
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
